FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the chemical-pharmaceutical industry and is a pharmaceutical composition having an anxiolytic effect containing an effective amount of N-(6-phenylhexanoyl)glycyl-L-tryptophan amide with a film coating and pharmaceutically acceptable auxiliaries suitable for use in pharmaceutical compositions.
EFFECT: invention makes it possible to increase the bioavailability of the N-(6-phenylhexanoyl)glycyl-L-tryptophan amide.
3 cl, 4 dwg, 3 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF N-(6-PHENYLHEXANOYL)GLYCYL-L-TRYPTOPHAN AMIDE IN SOLID DOSAGE FORM | 2013 |
|
RU2602742C2 |
| PHARMACEUTICAL COMPOSITIONS WITH PROLONGED RELEASE FOR TREATING CEREBROVASCULAR DISORDERS | 2014 |
|
RU2611339C2 |
| PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE WITH ANTIPSYCHOTIC ACTIVITY AND SYNTHESIS METHODS THEREOF | 2012 |
|
RU2584653C2 |
| PHARMACEUTICAL COMPOSITION BASED ON N-BUTYL-N-METHYL-1-PHENYLPYRROLO[1,2-a]PYRAZINE-3-CARBOXAMIDE | 2023 |
|
RU2811453C1 |
| PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
| COMPOSITION CONTAINING PARTICLES | 2015 |
|
RU2696482C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| USE OF AMIDE N-(6-PHENYLHEXANOYL) GLYCYL-L-TRYPTOPHANE (GB-115) AS AN AGENT HAVING ANXIOLYTIC PROPERTIES WITH AN ACTIVATING COMPONENT | 2018 |
|
RU2709013C1 |
| SOLID ENTERIC ORAL DOSAGE FORM OF PROINSULIN C-PEPTIDE (VERSIONS) AND METHOD FOR PREPARING IT (VERSIONS) | 2013 |
|
RU2522897C1 |
| METHOD OF INDUCING SATIETY | 2015 |
|
RU2690672C2 |
Authors
Dates
2018-08-08—Published
2013-12-13—Filed